<![CDATA[CCM Biosciences 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=44764>Wed, 13 May 2026 17:43:34 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 2025]]>https://www.newswire.co.kr/newsRead.php?no=1011773Fri, 23 May 2025 11:30:00 +0900<![CDATA[CCM 바이오사이언스, ASCO 2025에서 혁신적 AML 신약 프로그램 데이터 공개 예정]]>https://www.newswire.co.kr/newsRead.php?no=1011774Fri, 23 May 2025 11:30:00 +0900<![CDATA[CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025]]>https://www.newswire.co.kr/newsRead.php?no=1011764Fri, 23 May 2025 10:45:00 +0900<![CDATA[CCM 바이오사이언스, ASCO 2025에서 혁신적 비소세포폐암 신약 프로그램 데이터 공개]]>https://www.newswire.co.kr/newsRead.php?no=1011766Fri, 23 May 2025 10:45:00 +0900<![CDATA[CCM Biosciences Announces Launch of 5Prime Sciences Business Unit]]>https://www.newswire.co.kr/newsRead.php?no=981865Thu, 28 Dec 2023 14:30:00 +0900<![CDATA[CCM 바이오사이언스, 5Prime 과학 사업부 출범 발표]]>https://www.newswire.co.kr/newsRead.php?no=981866Thu, 28 Dec 2023 14:30:00 +0900